Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Você está prestes a deixar o site local do Brasil e será direcionado ao site global. Deseja continuar?
Não exibir esta mensagem novamente
Sim
Não

Voce Buscou por:

You Searched For:

INFORMAÇÕES RELACIONADAS

CONTATOS PRINCIPAIS

PRÓXIMOS EVENTOS

PRODUTOS RELACIONADOS

Produtos Farmacêuticos - Pensilvânia

Destaques

Relatórios
Empresas
Refine sua pesquisa por Segmento de Mercado para obter a Atividade de Rating e Watchlist correspondentes
  DataTipo de Documento Título Emissor/Entidade
28 Mar 2024 Credit Opinion Cencora, Inc.: Update to credit analysis following outlook revision to positive Cencora, Inc.
27 Mar 2024 Rating Action Moody's affirms Cencora's Baa2 senior unsecured rating, outlook revised to positive AmeriSource Hea...
Bergen Brunswig...
Bergen Brunswig...
Bergen Capital ...
Bergen Capital ...
Bergen Capital ...
Cencora, Inc.
Durr-Fillauer M...
PharMerica, Inc...
19 Mar 2024 Rating Action Moody's affirms GSK's A2 ratings; outlook remains stable GlaxoSmithKline...
GlaxoSmithKline...
GlaxoSmithKline...
GlaxoSmithKline...
GSK Capital B.V...
GSK Capital K.K...
GSK plc
13 Mar 2024 Peer Snapshot Cencora, Inc. - December 2023 (LTM): Peer Snapshot Cencora, Inc.
05 Feb 2024 Rating Action Moody's assigns Baa2 rating to Cencora's new senior notes Cencora, Inc.
22 Dec 2023 Peer Snapshot Cencora - September 2023 (LTM): Peer Snapshot Cencora, Inc.
17 Dec 2023 Rating Action Moody's affirms Teva's Ba2 ratings; outlook stable Teva Pharmaceut...
Teva Pharmaceut...
TEVA PHARMACEUT...
TEVA PHARMACEUT...
Teva Pharmaceut...
Teva Pharmaceut...
14 Dec 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Pharmaceutical issuers ADVANZ PHARMA H...
AI Sirona (Luxe...
Almirall, S.A.
AstraZeneca Fin...
AstraZeneca PLC
Cerebro HoldCo ...
Cheplapharm Arz...
Cidron Aida Fin...
Covis Finco S.a...
Covis Parent SC...
...
05 Oct 2023 Rating Action Moody's affirms Viatris' Baa3 rating; outlook remains stable Mylan Inc.
Mylan N.V.
Upjohn Finance ...
Viatris Inc.
29 Sep 2023 Announcement of Periodic Review Moody's announces completion of a periodic review for a group of Distribution and Supply Chain Services issuers AEC Parent Hold...
Allegiance Corp...
Avantor Funding...
Cardinal Health...
Cencora, Inc.
Covetrus, Inc.
Golden State Bu...
McKesson Corpor...
Owens & Minor, ...
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry